Last Updated:
NameDesignationAppointment DateStatus
Ganju Shibban Krishen

Appointed as Director since March 2010

Director25-Mar-2010Current
Hrishikesh Damle

Appointed as Director since July 2003

Director03-Jul-2003Current
Latha Damle

Appointed as Director since September 2021

Director09-Sep-2021Current
Rishi Ganju

Appointed as Director since September 2021

Director09-Sep-2021Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Atrimed Pharmaceuticals Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

People Timeline

Explore the timeline of key personnel in Atrimed Pharmaceuticals Private Limited's leadership journey.

Loading...
Contact Details
  • Address No.755, 3Rd Cross,11Th Block, 2Nd Stage, Bda Layout, Nagarbhavi Bangalore, Bangalore Karnataka, 560072, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
You can contact Atrimed Pharmaceuticals Private Limited through their registered address at No.755, 3Rd Cross,11Th Block, 2Nd Stage, Bda Layout, Nagarbhavi Bangalore, Bangalore Karnataka, 560072, India, or via their website at atrimed.com. Social media links are also provided where applicable.
The current directors of Atrimed Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • GANJU SHIBBAN KRISHEN
  • HRISHIKESH DAMLE
  • RISHI GANJU
  • LATHA DAMLE
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available